Leversense is commercializing an innovative new method for in vitro diagnostics technology. The technology, licensed from Drexel University, is a solid-state electromechanical sensor technology used to detect protein, nucleic acid and pathogen disease indicators. Ben Franklin Technology Partners of Southeastern PA has also invested $500,000 in the company.
Why Is Small So Big?
Nanotechnology deals with products and processes that are measured in almost unbelievably small increments called “nanometers”—one billionth of a meter.
At the nanoscale, materials differ from larger objects in their physical, chemical and biological properties; therefore, they lend themselves to new and improved materials, systems and devices. Nanotechnology is behind the development of such diverse advancements as:
- Drug Delivery
- Biofiltration and Separation sciences
- Improved coatings for medical devices
Thanks to rapid advances in this exciting new field, we now have the tools and talents to manipulate materials on the molecular scale—a technology literally changing the world as we know it.